| March 1 |
Pharmacopeia to Present Highlights From the Company's DARA Program
at the R. Bryan Miller Memorial Symposium |
| March 1 |
Pluristem Announces Scientific Advance in Stem Cell Research;
Evidence That PLX Cells Are Immunosuppressive |
| March 1 |
CollaGenex Pharmaceuticals Announces Positive Results of Phase 2
Dose-Finding Study of Incyclinide for the Treatment of Acne |
| March 1 |
Genelabs Announces Publication in New England Journal of Medicine
of Clinical Trial Results with Hepatitis E Virus Vaccine |
| March 1 |
Lowest FDA-Approved Dosage of Estradiol to Significantly Reduce Hot
Flashes Reported in Newly-Published Study |
| March 1 |
Affibody Molecules for Cancer Imaging Made by Chemical Synthesis |
| March 1 |
Excerpt of SEC Filnig by Amgen, Inc. |
| March 1 |
Study Published in New England Journal of Medicine: Vaccine 95.5%
Effective Against Neglected Hepatitis E |
| March 1 |
AVI BioPharma Presents Novel HIV Drug Candidate Results |
| March 1 |
Lorus Therapeutics Announces a Key Scientific Publication on
Therapeutic siRNA in Cancer Therapy |
| March 1 |
MAP Pharmaceuticals Reports Positive Phase 2 Results for its
Inhaled Migraine Drug Candidate |
| March 1 |
Schizophrenia Drug Studies: One Size Does Not Fit All; Community
Services Also Needed |
| March 1 |
New Details in Schizophrenia Treatment Trial Emerge |
| March 1 |
New Global Survey Shows Effective Patient-Physician Communication
Critical to Accurate and Timely Recognition of Neuropathic Pain |
| March 1 |
Idenix Announces Thirteen Data Presentations at the 2007 European
Association For the Study of the Liver |
| March 1 |
Lorus Therapeutics Announces a Key Scientific Publication on
Therapeutic siRNA in Cancer Therapy |
| March 1 |
Results with New Integrase Inhibitor Plus Fuzeon and Boosted
Protease Inhibitor Show Remarkable Undetectable Rate of 98 Percent
in Treatment-Experienced HIV Patients |
| March 1 |
Hepatitis Foundation International: New Study Supports
Effectiveness of Liver Wellness Education |
| March 1 |
Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces
Viral Load, in Combination Therapy Across Range of
Treatment-Experienced Patients |
| March 1 |
New Data on Investigational Agent TMC278 in Anitretroviral-Naive
HIV Patients |
| March 1 |
New Joslin Study Reveals How a Specific Fat Type Can Protect
Against Weight Gain and Diabetes |
| March 1 |
Results from Two Phase III Studies on Isentress (raltegravir,
MK-0518), Merck's Oral Investigational Integrase Inhibitor
Presented at the Annual Conference on Retroviruses and
Opportunistic Infections (CROI) |
| March 1 |
Monogram Provides Update on Trofile Assay - Pfizer Reports
Significant Reduction in Viral Load in Clinical Trial of Maraviroc |
| March 2 |
Gilead Announces 24-Week Results from Phase II Study of
Investigational HIV Integrase Inhibitor GS 9137 |
| March 2 |
Preclinical Data From Two Novel Idenix Compounds for the Treatment
of HIV Presented at Conference on Retroviruses and Opportunistic
Infections (CROI) |
| March 2 |
Bradley Pharmaceuticals Low-Dose Estrogen Therapy Supported by
Recent Medical Literature |
| March 2 |
Recent HPV Findings by Centers for Disease Control and Prevention
Validate Advaxis, Inc.'s Treatable Population |
| March 5 |
New Studies Indicate GSK's Pre-Pandemic Influenza Vaccine Can
Protect Against Different Strains of H5N1 |
| March 5 |
LAB International Announces Positive Results from the Open-Label
Phase IIb Fentanyl Taifun Trial - New Patent Application Submitted |
| March 5 |
Phenomix Completes Phase 2a Clinical Trial - Diabetes Drug is
Efficacious and Well Tolerated |
| March 5 |
Memory Pharmaceuticals Reports Phase 2a Results for MEM 1003 in
Bipolar Disorder |
| March 5 |
Transition Therapeutics Announces Positive Data from E1-I.N.T.
Clinical Trials in Type 1 and Type 2 Diabetes Patients |
| March 5 |
Collegium Pharmaceutical Announces Successful Completion of Proof
of Concept Clinical Trial for Novel Combination Allergic Rhinitis
Product |
| March 5 |
Iomai Vaccine for Travelers' Diarrhea Blunts Severity of Disease in
Clinical Study |
| March 5 |
Study Shows Nonsurgical Treatment Reduces Neck Pain Without
Significant Risk of Paralysis |
| March 5 |
Myriad Presents Additional Flurizan Phase 2 Study Data
Demonstrating Benefit in Alzheimer's Patients |
| March 5 |
Study Examines Genetic Risk Factors for Alzheimer's Disease |
| March 5 |
Cytheris Releases Promising Clinical Data on its Interleukin-7
Immune Enhancer at the 2007 CROI Meeting in Los Angeles |
| March 5 |
Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at
the Fourth International Conference on Tumor Microenvironment in
Florence, Italy |
| March 6 |
Replidyne Phase II Pediatric Trial Meets Primary Objective |
| March 6 |
POZEN Announces Positive Outcome for PA 325 Proof of Concept Study |
| March 6 |
Advanced Magnetics Announces Presentation of Ferumoxytol Data at
the National Kidney Foundation 2007 Spring Clinical Meetings |
| March 6 |
Pozen Announces Positive Outcome for PA 325 |
| March 6 |
DVT Awareness Survey Findings: Heart and Respiratory Patients |
| March 6 |
Nventa Announces Presentation of Positive HspE7 Data from
NCI-Sponsored Clinical Trial in Cervical Dysplasia |
| March 6 |
AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II
Study with Novel Cystic Fibrosis Therapy |
| March 6 |
Advanced Cell Technology's Ability to Rescue Vision in Blind Rats
Noted in Scientific American |
| March 7 |
CeNeS Pharmaceuticals plc: Update on Successful Phase III results
announced on Lead Product M6G |
| March 7 |
Actelion Announces Positive Study with Bosentan (Tracleer) in
CTEPH |
| March 7 |
CV Therapeutics Announces Topline MERLIN TIMI-36 Results |
| March 7 |
American Society of Clinical Oncology (ASCO) Accepts New Data on
AVR118 for Publication in 2007 Abstract Book |
| March 7 |
BioLineRx Presents Data on BL-1040 at Cardiovascular
Revascularization Therapies Conference Demonstrating Potential to
Reduce Deterioration of Infarcted Heart Tissue and Maintain
Functionality |
| March 7 |
Gemin X Announces Publication of Preclinical Data of GX15-070 in
Multiple Myeloma in Blood |
| March 7 |
Accentia Biopharmaceuticals Scientific Presentations Demonstrate
Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at
the Annual Meeting of the American Academy of Allergy, Asthma, and
Immunology |
| March 7 |
Major Gene Study Uncovers Secrets of Leukemia |
| March 7 |
British Journal of Cancer Reports Preclinical Evidence of Positive
Effect of Rice Bran on Intestinal Cancer |
| March 8 |
Hollis-Eden Announces Cancellation of Acute Radiation Syndrome RFP
by Department of Health and Human Services |
| March 8 |
La Jolla Pharmaceutical Announces Positive Interim Antibody Results
From Riquent Lupus Phase 3 Trial |
| March 8 |
Arpida adds novel antibiotic AR-2474 to its preclinical pipeline |
| March 8 |
Antisoma plc (UK) - Second lung cancer trial adds to positive data
on AS1404 |
| March 8 |
Data From Adherex's European Phase Ib/II Trial of ADH-1 to be
Presented at International Symposium on Targeted Anticancer
Therapies |
| March 8 |
IR BioSciences Announces Data Demonstrating Radilex Stimulation of
Stem Cells Results in Hematopoietic Recovery Following Lethal
Irradiation |
| March 8 |
Newly Released Canadian Data Links Vaccines with Pervasive
Developmental Disorder |
| March 8 |
Study in Cell by Magen BioSciences Co-Founder David E. Fisher
Identifies New Roles in Skin Cancer Prevention for Key Tumor
Suppressor Protein |
| March 8 |
Weight Management is Not Enough for Cannabinoid Type 1 (CB1)
Receptor Antagonists to Become a Commercial Success |
| March 8 |
Scottish Scientists Test ‘Secret Weapon’ Against
Tumours |
| March 8 |
Why Is Polio Spreading in Pakistan? |
| March 9 |
Vaxiion Researchers Discover Novel Vaccine Delivery System in
Collaboration with San Diego State University |
| March 9 |
Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 |
| March 9 |
Positive Clinical Data for TASQ - Active Biotech's Novel Treatment
of Prostate Cancer |
| March 9 |
Nearly 1 in 10 Americans Has A Relative With Kidney Failure |
| March 12 |
Chemokine Therapeutics Announces Preliminary Results of CTCE-9908
Phase Ib/II Clinical Trial in Late Stage Cancer Patients |
| March 12 |
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients
With Relapsing Multiple Sclerosis |
| March 12 |
Preclinical Update - Debio-0512 Therapeutic Vaccine for the
Treatment of Chronic and Acute Inflammatory Conditions |
| March 12 |
GenoMed Prevents Sickle Cell Pain for Over a Year |
| March 12 |
Schering-Plough Announces Presentation of Phase II Trial Results
for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual
Meeting of The American College of Cardiology/i2 Summit |
| March 12 |
Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm
Formation in 21 Day Study |
| March 12 |
Integrated Biopharma's Proprietary Vaccine Technology Achieves
Strong Positive Results |
| March 12 |
Integrated BioPharma's Proprietary Vaccine Technology Achieves
Strong Positive Results |
| March 12 |
PI-88 Data to be Presented at Key International Conferences |
| March 13 |
CeNeRx BioPharma Announces Positive Phase I Results in First Human
Trial of Third Generation RIMA Antidepressant |
| March 13 |
Framingham Study Shows Parents Who Live Long Pass On Lower Risk of
Cardiovascular Disease |
| March 13 |
Oncolytics Biotech Inc. Collaborators to Present
Reovirus/Gemcitabine Combination Research at AACR Annual Meeting |
| March 13 |
Active Biotech's I-3D Micro-dosing Clinical Trial Concluded |
| March 13 |
Placebo-controlled Phase IIa Study with the Immunotherapeutic
CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in
Hay Fever Patients |
| March 13 |
Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:
Potential Mitigating Factors Identified which Prevent Clear
Interpretation of Results |
| March 14 |
JACC Publishes Long-Term Safety and Tolerability Data from
Ranolazine Open Label Experience (ROLE) Program |
| March 14 |
Use of Sequenom's MassARRAY System Leads to Significant Scientific
Advances in Understanding Cancer, Diabetes and Drug-Resistant
Malaria |
| March 14 |
Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III
Trial for Hereditary Angioedema |
| March 14 |
Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007
AACR Annual Meeting |
| March 14 |
Study of Drug Therapy for Compulsive Buying Yields a Puzzle,
Stanford Researcher Says |
| March 14 |
Pharmaxis Reports Phase II Results for Aridol in COPD |
| March 14 |
AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial
with Alkaline Phosphatase in Acute Renal Failure |
| March 15 |
One-Third of Patients Discontinue Common Breast Cancer Therapy |
| March 15 |
Stanford Study Finds No Conclusive Benefit From Treating
Kleptomania With Medication |
| March 15 |
Intercell AG: Novel tuberculosis Vaccine Shows Promising
Immunogenicity and Safety Profile |
| March 15 |
DVT Awareness Survey Findings for Respondents in High-Risk Groups:
Obese Individuals |
| March 15 |
ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met
Inhibitor, for Oral Presentation at ASCO |
| March 15 |
The Medicines Company Products Angiomax (bivalirudin) and Cleviprex
(clevidipine) Featured in Three Late Breaking Trials at American
College of Cardiology Annual Scientific Session |
| March 15 |
Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice |
| March 16 |
Media Advisory: ACC Updated Schedule |
| March 16 |
Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219
to be Presented at AACR |
| March 19 |
Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data
Selected for Scientific Highlights Program at the American Academy
of Neurology Meeting |
| March 19 |
New Phase IV Clinical Study Indicates LidoSite Provides
Rheumatology Patients Superior Pain Relief |
| March 19 |
Coronary Artery Disease ARISE Trial Showed AGI-1067 Did Not Meet
Primary Endpoint |
| March 19 |
Seroquel Sustained Release Schizophrenia Data Presented at ECP
Congress in Madrid |
| March 19 |
In New Study, Duloxetine Reduced Non-specific Pain and Emotional
Symptoms Associated with Depression |
| March 19 |
Acadia Announces Positive Results From ACP-103 Phase II
Schizophrenia Co-Therapy Trial |
| March 19 |
Abbott to Present New Data Across its Vascular Portfolio at the
American College of Cardiology's 56th Annual Scientific Session |
| March 19 |
AtheroGenics Reports ARISE Trial Results for AGI-1067 |
| March 19 |
Avid Announces Results of AV-1 Molecular Imaging Agent for
Alzheimer's Disease Presented at AD/PD Meeting |
| March 19 |
Nymox Announces Positive Results from Newly Completed Long-term
Study of NX-1207 for Benign Prostatic Hyperplasia |
| March 19 |
Nuvelo Announces Presentation on rNAPc2 at American College of
Cardiology 56th Annual Scientific Session |
| March 19 |
Medivation Announces Presentation of Full Top-Line Data From
Dimebon Six-Month Trial at Major International Alzheimer's Disease
Conference |
| March 19 |
Amicus Therapeutics Presents Data From Preclinical and Phase 1
Studies of Amigal for Fabry Disease |
| March 20 |
Calando Pharmaceuticals Publishes the First Non-Human Primate Study
on Targeted, Systemic Delivery of siRNA in National Academy of
Sciences Journal |
| March 20 |
Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on
Targeted, Systemic Delivery of siRNA |
| March 20 |
MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study
of Aquavan Injection in Patients Undergoing Bronchoscopy |
| March 20 |
La Jolla Pharmaceutical Provides Update on Interim Antibody Results
From Riquent Lupus Phase 3 Trial |
| March 20 |
Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor
Data Showing Broad Anti-Tumor Activity, Dosing Flexibility |
| March 20 |
ImmuneRegen BioSciences Announces Promising Data on Homspera
Suggesting Potential as a Co-Therapeutic Agent |
| March 20 |
Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain
Associated With Insertion of an Intravenous Catheter in Their Phase
2 Clinical Trial |
| March 20 |
REACH Registry Demonstrates That Multiple Arterial Disease
Locations Sharply Increase the Risk of Major CV Events in
Outpatients With Atherothrombosis |
| March 20 |
Corcept Therapeutics Announces Phase 3 Study Evaluating Corlux for
Psychotic Major Depression Misses Primary Endpoint |
| March 20 |
Hospitalization Rates for Coronary Artery Disease Decline in the
U.S. |
| March 20 |
Avexa Reports Positive Phase IIb Result |
| March 20 |
Amicus Therapeutics Presents Preclinical Data from Studies of
Plicera for Gaucher Disease |
| March 20 |
Alfacell's Onconase Highlighted in Latest Edition of Handbook of
Therapeutic Antibodies |
| March 20 |
New Data from the US and Japan Support: No Established Causal Link
Between Neuropsychiatric Symptoms and Treatment with Tamiflu US
Databases Indicate Psychiatric Symptoms Lower in Influenza Patients
Taking Tamiflu Versus Those Not Taking Tamiflu |
| March 20 |
Researchers Find Surprising Pattern of Influenza Spread in South
America and Tropics |
| March 20 |
Protein Found to Shield Pancreatic Cancer Cells from
Self-Destruction |
| March 20 |
Protox Announces Publication in Journal of the National Cancer
Institute Supporting PRX302 as Treatment for Prostatic Diseases |
| March 21 |
The American Liver Foundation Urges Cautious Optimism about CDC
Report on Declining Acute Hepatitis Infection Rates |
| March 21 |
Amicus Therapeutics Presents Positive Results From Phase 1 Clinical
Studies of Plicera for Gaucher Disease |
| March 21 |
Alzheimer's Growth Shows Need for Increased FDA Funding |
| March 21 |
Medical Journal Publishes First Large-Scale Survey Revealing
Experiences of IPF Patients |
| March 21 |
Research Results on FluMist Presented at National Association of
Pediatric Nurse Practitioners Conference |
| March 22 |
AEterna Zentaris Reports Positive Results with Cetrorelix in BPH
for Japanese Phase 2a Trial |
| March 22 |
Isis Pharmaceuticals Announces Its Participation at the Upcoming
ACC 56th Annual Scientific Session in New Orleans and Its Live
Analyst/Investor Webcast Presentation |
| March 22 |
Additional Data From Satraplatin SPARC Phase 3 Trial Presented at
European Association of Urology Congress |
| March 22 |
Nutra Pharma Announces Publication of Research on Treatment for
Multiple Sclerosis |
| March 22 |
Aeolus Pharmaceuticals Announces Successful Completion of Multiple
Dose Safety Study of AEOL 10150 |
| March 22 |
Laresse Dermal Filler Research Presented at Anti-Aging World
Congress |
| March 22 |
Studies Show Mild Hyperthermia Enhances Antitumor Effects of
Alfacell's Onconase |
| March 22 |
Alnylam and Stanford University Scientists Discover New Role for
microRNAs (miRNAs) in T Cell Biology and Immunity |
| March 23 |
Major Discovery Raises Prospect of Better Patient Care By Improving
Platelet Life Span |
| March 23 |
Sarasota's Roskamp Institute Announces Positive Safety Data in
Human Clinical Study for Alzheimer's Disease |
| March 23 |
ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH |
| March 23 |
Leukemic Cells Find Safe Haven in Bone Marrow |
| March 23 |
Metabasis Therapeutics to Present Poster at American Association
for Cancer Research |
| March 23 |
Viral Enzyme Recruited in Fight Against Ear Infection |
| March 23 |
MUSC Research Offers Hope for Those Resistant to Depression
Treatment |
| March 23 |
Study Shows Metabolic Strategy of Stressed Cell |
| March 26 |
New Clinical Data for Cytogen's Quadramet and Prostacint to be
Reported at Upcoming Major Medical Meetings |
| March 26 |
EntreMed Presents Mechanism Data for Its Three Lead Oncology
Compounds |
| March 26 |
First Study To Show Positive Benefit On Atherosclerosis For People
With Early Signs Of Diseased Arteries |
| March 26 |
Abbott Announces Positive Six-Month Results From the World's First
Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent |
| March 26 |
Abbott's Xience V Everolimus Eluting Coronary Stent Superior to
Taxus Stent in Spirit III U.S. Pivotal Clinical Trial |
| March 26 |
Inovio Biomedical's DNA Delivery Technology Significantly Enhances
Potency of HIV DNA Vaccine |
| March 26 |
Inimex Product Candidate is First Immune Defense Regulator to Cure
Infections Without Causing Harmful Inflammation |
| March 26 |
In vivo Study Results Demonstrating Potential of Alfacell's
Onconase for Treatment of Non-Small Cell Lung Cancer Published in
Anticancer Research |
| March 26 |
Everest Data on Short- and Long-Term Use of Otsuka's
Investigational Novel Treatment, Tolvaptan, Published in Journal of
the American Medical Association and Featured in ACC's Late
Breaking Clinical Trials |
| March 26 |
Scios Announces Results From Exploratory Nesiritide Study Providing
Important New Renal and Mortality Safety Data with a Neutral Effect
on the Primary Endpoint |
| March 26 |
Cholesterol Drug Fails to Slow Progression of Coronary Disease,
Cleveland Clinic Study Reports |
| March 26 |
Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2
Predicts Heart Disease Risk in Metabolic Syndrome Patients |
| March 26 |
Tekturna, First New Type of High Blood Pressure Medicine in a
Decade, Provides Additional Blood Pressure Reduction When Used With
Diovan |
| March 26 |
Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012
in Familial Hypercholesterolemia Patients Presented at ACC |
| March 26 |
Diobex Announces Successful Completion of Phase 2a Trial Of
DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes |
| March 26 |
Study: Identical Doses of BiDil Components Are Not Bioequivalent to
the Fixed Dose Combination-BiDil-Used in A-HeFT |
| March 26 |
Two New Imaging Studies Show Higher Dose Lipitor Stopped the
Progression of Atherosclerosis |
| March 26 |
Cypher Sirolimus-eluting Coronary Stent Had Similar Results to
Bypass Surgery in Long-Term Study of Patients With Multi-Vessel
Coronary Artery Disease |
| March 26 |
Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm
Stent's Positive Clinical Profile |
| March 26 |
CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume
in Coronary Arteries |
| March 26 |
Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and
Effective Treatment to Reduce Risk of Stroke |
| March 26 |
Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating
Schizophrenic Patients With Acute Agitation |
| March 26 |
Acuity One-Year Findings Meet All Primary Endpoints in Favor of
Angiomax (Bivalirudin) Alone Treatment Group |
| March 26 |
Calcium Plaque Build-up in the Arteries Leads to Coronary Heart
Disease in Multi-Ethnic Groups |
| March 26 |
Two-Year Patient Registry Results Support Safety and Efficacy of
Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses |
| March 27 |
Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV
Activity |
| March 27 |
Afid Therapeutics Obtains Positive Evaluation of its Triple Mode
Viral Sequestration Agents |
| March 27 |
Landmark Findings From ECLIPSE Program Show Improved Control of
Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery |
| March 27 |
Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in
Age-Related Macular Degeneration |
| March 27 |
Study Presented at ACC Shows Treatment With ISIS 301012 Added to
Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C
Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C
Levels of Less Than 70 mg/dL |
| March 27 |
MediciNova Announces Positive Clinical Results From MN-166 Phase II
Multiple Sclerosis Trial |
| March 27 |
Lipitor Provides Unprecedented Cardiovascular Risk Reductions in
Diabetes Patients with Metabolic Syndrome and in Stroke Patients |
| March 27 |
PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results
Demonstrate Safety and Efficacy at Once-Weekly Dosing |
| March 27 |
CombinatoRx Provides Topline Results from Phase 2 RA Study with
CRx-139 and Very Low Dose Prednisolone |
| March 27 |
Survey Reveals Significant Public Lack of Diabetes Awareness |
| March 27 |
Curecumin May Be an Effective Treatment for Lung Cancer |
| March 27 |
Interferon Beta DNA Treatment Delivered with Ichor Technology
Reduces Atherosclerosis Progression in Mice |
| March 27 |
Isotechnika's independent data monitoring committee conducts review
of phase 2b kidney transplant trial |
| March 27 |
Pivotal Phase III Findings With Investigational Drug Cleviprex
(Clevidipine) Demonstrate Perioperative Blood Pressure Control In
Cardiac Surgery |
| March 27 |
Lipitor Significantly Lowered Hospitalization Costs for Patients
with Heart Disease, Two New Analyses Show |
| March 27 |
Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical
Data for INO-1001 at ACC Demonstrating PARP Inhibition and
Anti-inflammatory Activity in Plasma of Patients Undergoing Primary
Percutaneous Coronary Intervention |
| March 27 |
Heart Attack Patients Treated With Novel Stem Cell Therapy
Experience Significant Improvement in Heart and Lung Function |
| March 27 |
Increasing Proportion of Cardiovascular Disease Due to Diabetes
Over the Last 50 Years |
| March 28 |
ACC Presentation Indicates Interleukin-1 Gene Variants Determine
Increased Risk for Coronary Artery Disease from Oxidized
Phospholipids |
| March 28 |
Ace Biosciences, Ace393, the World's First Commercial Vaccine for
Travellers' Diarrhoea Caused by Campylobacter Successfully
Completes Phase I Clinical Trials |
| March 28 |
Calcium Channel Blocker Adalat GITS Offer Additional Benefits |
| March 28 |
CSL Therapy That Mimics “Good” Cholesterol May Reduce
Plaque Volume in Coronary Arteries |
| March 28 |
Biosite Reports on Presentation of Preliminary Data From Sepsis
Program |
| March 28 |
CeNeS Pharmaceuticals Plc Announces Preliminary Results for The
Year Ending 31 December 2006 |
| March 28 |
Diabetes Linked to Higher Parkinson's Risk |
| March 28 |
Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,
Its New Long Acting Drug For Erectile Dysfunction |
| March 28 |
MRI Detects Cancers in the Opposite Breast of Women Newly Diagnosed
with Breast Cancer |
| March 28 |
New Study Confirms Role for Pertussis Immunization of Entire Family
in Reducing Infant Pertussis |
| March 29 |
Preclinical Data on Cytogen's Technology to be Reported at the AACR
Annual Meeting |
| March 29 |
Arpida Announces Promising Results of "First-In-Man" Studies With
AR-709 |
| March 29 |
Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery
of GLP-1 and PYY |
| March 29 |
Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic
Effect in New Primate Model of Established Anthrax Infection |
| March 29 |
Pieris Demonstrates Potent Anti-Tumor Activity of a VEGF-Specific
Anticalin in Preclinical Studies |
| March 29 |
ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual
Meeting |
| March 29 |
Baxter Announces Final Phase I/II Data and Initiation of Phase III
Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine |
| March 29 |
Portola Pharmaceuticals Presents Positive Phase I Data of Its ADP
Receptor Antagonist at the American College of Cardiology |
| March 29 |
Orapred ODT Tastes Good |
| March 29 |
Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting
Protective Antibody Response in Mucosal Tissues of Non-Human
Primate Model |
| March 29 |
ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at
the 2007 International Congress on Schizophrenia Research |
| March 29 |
Study Sheds Light on Medication Treatment Options for Bipolar
Disorder |
| March 29 |
Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic
Effect in New Primate Model of Established Anthrax Infection |
| March 30 |
Safety Analyses of Clinical Data for Bifeprunox in Patients with
Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar
to Placebo |
| March 30 |
Presentations at American College of Cardiology Meeting Highlight
New Opportunities for HDL Therapy |
| March 30 |
Study Suggests Invega Helps Patients With Schizophrenia Maintain
Symptom Control |
